Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, PMV Pharmaceuticals Inc (NASDAQ: PMVP) closed at $0.87 down -7.34% from its previous closing price of $0.94. In other words, the price has decreased by -$7.34 from its previous closing price. On the day, 0.75 million shares were traded.
Ratios:
For a deeper understanding of PMV Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.22 and its Current Ratio is at 12.22. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
On May 13, 2024, Craig Hallum started tracking the stock assigning a Buy rating and target price of $6.
On April 12, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $5.Jefferies initiated its Buy rating on April 12, 2024, with a $5 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 11 ’24 when Jalota Deepika sold 7,218 shares for $1.50 per share. The transaction valued at 10,853 led to the insider holds 118,283 shares of the business.
Carulli Michael sold 2,891 shares of PMVP for $4,347 on Sep 11 ’24. The Chief Financial Officer now owns 88,395 shares after completing the transaction at $1.50 per share.
Stock Price History:
Over the past 52 weeks, PMVP has reached a high of $2.26, while it has fallen to a 52-week low of $0.82. The 50-Day Moving Average of the stock is -22.79%, while the 200-Day Moving Average is calculated to be -39.19%.
Shares Statistics:
A total of 51.94M shares are outstanding, with a floating share count of 43.75M. Insiders hold about 15.79% of the company’s shares, while institutions hold 71.34% stake in the company.
